GO:0006644 phospholipid metabolic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006644 phospholipid metabolic process describes the chemical reactions and pathways involving phospholipids, any lipid containing phosphoric acid as a mono- or diester.
• Phospholipid metabolism is essential for membrane biogenesis, lipid homeostasis, and the generation of signaling molecules.
• Key enzymes and transporters include PCYT1A, PEMT, MBOAT1/2, ABCA1, and phospholipid transfer proteins such as PITPNA and CERT1.
• Disrupted phospholipid metabolism is linked to cancer, neurodegeneration, and metabolic disorders.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of phospholipid metabolic genes.
• Studying this process requires integrated methods such as lipidomics, imaging, and CRISPR library screening.
Description
Phospholipid metabolic process (GO:0006644) encompasses the chemical reactions and pathways involving phospholipids, which are essential structural components of cellular membranes and key players in signal transduction. Phospholipids are amphipathic molecules containing a glycerol or sphingosine backbone, a phosphate group, and two fatty acid chains, and their metabolism is tightly regulated to maintain membrane integrity and cellular function. This process is fundamental to all living organisms, as it governs the synthesis, remodeling, transport, and degradation of phospholipids across various organelles. Researchers study phospholipid metabolism to understand how cells maintain lipid homeostasis, respond to stress, and regulate processes such as cell growth, apoptosis, and autophagy. Dysregulation of phospholipid metabolism has been implicated in a wide range of human diseases, including cancer, cardiovascular disorders, and neurodegenerative conditions. Therefore, elucidating the molecular mechanisms of phospholipid metabolic process is critical for identifying therapeutic targets and developing novel interventions.
phospholipid metabolic process At A Glance
| GO ID | GO:0006644 |
|---|---|
| GO term | phospholipid metabolic process |
| Ontology | biological_process |
| Synonym | phospholipid metabolism |
| Major function | Synthesis, remodeling, transport, and degradation of phospholipids for membrane biogenesis and signaling |
| Key enzymes | PCYT1A, PEMT, MBOAT1/2, PLA2G, PLC, PLD |
| Subcellular locations | Endoplasmic reticulum, mitochondria, Golgi, plasma membrane |
| Related pathways | Glycerophospholipid metabolism, sphingolipid metabolism, lipid transport |
What Is GO:0006644?
Phospholipid metabolic process (GO:0006644) is defined as the chemical reactions and pathways involving phospholipids, any lipid containing phosphoric acid as a mono- or diester. This includes the biosynthesis of phospholipids from precursors such as glycerol, fatty acids, and phosphate, their remodeling through deacylation and reacylation cycles, their transport between organelles, and their degradation by phospholipases. The process is essential for maintaining membrane lipid composition and for generating lipid second messengers.
Why Is phospholipid metabolic process Important in Cell Biology?
Phospholipid metabolic process is vital for cellular life because phospholipids are the primary building blocks of biological membranes and serve as precursors for signaling molecules. Proper regulation of this process ensures membrane fluidity, permeability, and protein function, while its dysregulation contributes to numerous pathologies including cancer, neurodegeneration, and metabolic syndrome. Understanding phospholipid metabolism provides insights into fundamental cell biology and offers potential targets for therapeutic intervention.
• Maintains membrane integrity and organelle identity.
• Generates lipid second messengers such as phosphatidic acid and diacylglycerol.
• Supports lipoprotein secretion and lipid transport.
• Regulates autophagy and membrane remodeling.
• Implicated in cancer cell proliferation and survival.
• Linked to neurodegenerative diseases such as Alzheimer's and Parkinson's.
• Plays a role in cardiovascular disease and atherosclerosis.
• Affects insulin sensitivity and metabolic disorders.
• Provides targets for drug discovery and biomarker development.
• Essential for viral replication and host-pathogen interactions.
What Happens During phospholipid metabolic process?
Phospholipid Biosynthesis
In simple terms: Cells build new phospholipids from simple precursors like glycerol and fatty acids.
Phospholipid biosynthesis occurs mainly in the endoplasmic reticulum (ER) and involves the sequential action of acyltransferases, phosphatases, and choline/ethanolamine phosphotransferases. The Kennedy pathway is a primary route for phosphatidylcholine and phosphatidylethanolamine synthesis, utilizing CDP-choline or CDP-ethanolamine intermediates. Phosphatidylserine is synthesized by base-exchange reactions, while phosphatidylinositol is produced from CDP-diacylglycerol and inositol. These reactions are tightly regulated to meet cellular demands for membrane expansion and signaling.
Phospholipid Remodeling
In simple terms: Existing phospholipids are edited by swapping fatty acid chains to adjust membrane properties.
Phospholipid remodeling, also known as the Lands cycle, involves deacylation by phospholipase A2 and reacylation by lysophospholipid acyltransferases. This cycle generates diversity in acyl chain composition, which influences membrane fluidity, curvature, and protein interactions. Remodeling is crucial for adapting membranes to changing environmental conditions and for producing lipid mediators such as arachidonic acid derivatives.
Phospholipid Transport
In simple terms: Phospholipids are moved between organelles by specialized proteins to maintain distinct membrane compositions.
Phospholipid transport between organelles occurs via vesicular and non-vesicular mechanisms. Non-vesicular transport is mediated by lipid transfer proteins (LTPs) such as PITPNA, CERT1, and OSBP, which shuttle phospholipids between membranes at membrane contact sites. Mitochondria receive phospholipids from the ER through MAMs (mitochondria-associated membranes). TMEM41B and CLCC1 have been identified as ER scramblases that facilitate phospholipid distribution and lipoprotein biogenesis.
Phospholipid Degradation and Signaling
In simple terms: Phospholipids are broken down to release signaling molecules and recycle components.
Phospholipases (PLA1, PLA2, PLC, PLD) hydrolyze phospholipids to generate lysophospholipids, fatty acids, diacylglycerol, inositol trisphosphate, and phosphatidic acid. These products act as second messengers in signal transduction pathways, influencing cell growth, differentiation, and apoptosis. Degradation also allows recycling of fatty acids and phosphate for new lipid synthesis.
Key Genes Involved in GO:0006644 phospholipid metabolic process
The following genes encode enzymes, transporters, and regulatory proteins that directly participate in phospholipid metabolic process.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PCYT1A | CTP:phosphocholine cytidylyltransferase, rate-limiting enzyme in phosphatidylcholine synthesis | Knockout causes membrane defects; target for cancer and metabolic studies |
| PEMT | Phosphatidylethanolamine N-methyltransferase, converts PE to PC in liver | Knockout leads to hepatic steatosis; model for liver disease |
| MBOAT1 | Lysophospholipid acyltransferase involved in phospholipid remodeling | Knockout affects membrane composition; studied in inflammation |
| MBOAT2 | Acyltransferase for phospholipid remodeling | Role in cancer cell proliferation |
| PLA2G4A | Cytosolic phospholipase A2, releases arachidonic acid | Involved in inflammation and cancer; knockout models available |
| PLCB1 | Phospholipase C beta 1, generates IP3 and DAG | Knockout affects neuronal signaling; linked to epilepsy |
| PITPNA | Phosphatidylinositol transfer protein alpha | Essential for PI transport; knockout is embryonic lethal |
| CERT1 | Ceramide transfer protein, also transfers phospholipids | Knockout affects sphingolipid and phospholipid homeostasis |
| ABCA1 | ATP-binding cassette transporter, flops phospholipids to outer leaflet | Mutations cause Tangier disease; knockout model for cholesterol efflux |
| TMEM41B | ER scramblase required for lipoprotein biogenesis | Knockout impairs lipid homeostasis; linked to viral replication |
| CLCC1 | ER bilayer equilibration factor | Knockout causes lipid imbalance; studied in neurodegeneration |
| VPS13A | Lipid transfer protein at membrane contact sites | Mutations cause chorea-acanthocytosis |
| VPS13B | Lipid transfer protein | Mutations cause Cohen syndrome |
| OSBP | Oxysterol-binding protein, transfers cholesterol and phospholipids | Knockout affects Golgi lipid composition |
| CCTalpha | Chaperonin containing TCP1 subunit alpha, may interact with phospholipid enzymes | Potential regulator of lipid metabolism |
| LPCAT1 | Lysophosphatidylcholine acyltransferase 1 | Knockout affects lung surfactant; studied in cancer |
| LPCAT3 | Lysophosphatidylcholine acyltransferase 3 | Regulates membrane polyunsaturation; knockout causes ER stress |
| SPTLC1 | Serine palmitoyltransferase, first step in sphingolipid synthesis | Knockout affects sphingolipid metabolism; linked to neuropathy |
How Is phospholipid metabolic process Regulated?
Phospholipid metabolic process is regulated at multiple levels, including transcriptional control by SREBPs and nuclear receptors, post-translational modification of enzymes, and feedback inhibition by lipid products. The ER senses phospholipid imbalance and activates the unfolded protein response and autophagy to restore homeostasis. Additionally, phospholipid transfer proteins and scramblases are regulated by calcium and phosphorylation to meet dynamic cellular needs.
phospholipid metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PCYT1A | Cancer, membrane synthesis | Knockout and overexpression in cancer cell lines |
| PEMT | Non-alcoholic fatty liver disease | Liver-specific knockout mouse |
| ABCA1 | Tangier disease, atherosclerosis | Knockout iPSC-derived macrophages |
| VPS13A | Chorea-acanthocytosis | Knockout neuronal cells |
| TMEM41B | Lipid homeostasis, viral infection | Knockout hepatocytes |
Cancer
Altered phospholipid metabolism is a hallmark of cancer, supporting rapid membrane synthesis and signaling for proliferation. Overexpression of choline kinase alpha and phosphatidylcholine-specific phospholipase C promotes tumor growth. Targeting phospholipid metabolic enzymes such as PCYT1A and PLA2G4A is a promising therapeutic strategy.
Neurodegeneration
Defects in phospholipid transport and remodeling contribute to neurodegenerative diseases such as Alzheimer's and Parkinson's. Mutations in VPS13A and VPS13B cause chorea-acanthocytosis and Cohen syndrome, respectively, highlighting the importance of lipid transfer proteins in neuronal function. CLCC1 dysfunction leads to ER lipid imbalance and neurodegeneration in model systems.
Metabolic Disorders
Dysregulation of phospholipid metabolism is linked to obesity, insulin resistance, and non-alcoholic fatty liver disease. TMEM41B and CLCC1 are critical for lipoprotein secretion, and their loss impairs lipid homeostasis. PEMT deficiency causes hepatic steatosis, illustrating the role of phospholipid synthesis in liver health.
From phospholipid metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate phospholipid synthesis? | CRISPR knockout in HeLa or HEK293 cells |
| What is the effect of a point mutation in enzyme Y? | CRISPR point mutation knock-in |
| How does tagging affect protein localization? | Knock-in of fluorescent tag |
| Can overexpression rescue lipid defects? | CRISPR overexpression (CRISPRa) or cDNA overexpression |
| Which genes are essential for phospholipid metabolism? | Genome-wide CRISPR library screening |
| What are the metabolic consequences of gene Z loss? | Lipidomics and metabolomics in knockout cells |
How to Study the phospholipid metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS) | Phospholipid species and acyl chain composition | Profiling knockout cells |
| Fluorescence microscopy | Subcellular localization and dynamics | Live-cell imaging of lipid probes |
| CRISPR knockout screening | Gene essentiality and lipid homeostasis | Discovery of novel regulators |
| Enzyme activity assay | Catalytic activity of phospholipid enzymes | Validation of point mutations |
| Immunoblotting | Protein expression and organelle markers | Subcellular fractionation |
| RNA-seq | Transcriptional changes in lipid genes | Pathway analysis |
| Proteomics | Protein interactions and abundance | Identifying complexes |
Lipidomics
Mass spectrometry-based lipidomics enables comprehensive profiling of phospholipid species, revealing changes in abundance and acyl chain composition upon genetic perturbation. This method is essential for validating CRISPR knockout phenotypes and identifying metabolic pathways affected.
Imaging
Fluorescence microscopy with lipid-binding probes (e.g., GFP-PH domains) and live-cell imaging visualizes phospholipid distribution and dynamics in real time. Super-resolution microscopy can resolve membrane contact sites and lipid transfer events.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens coupled with lipid reporters or viability assays identify novel regulators of phospholipid metabolism. These screens are powerful for discovering genes that control lipid homeostasis.
Biochemical Assays
In vitro enzyme assays using radiolabeled substrates measure phospholipid synthesis, remodeling, and degradation activities. Subcellular fractionation followed by immunoblotting localizes enzymes to specific organelles.
How CRISPR Can Be Used to Study GO:0006644 phospholipid metabolic process
Knockout
CRISPR knockout of phospholipid metabolic genes (e.g., PCYT1A, PEMT, TMEM41B) in cell lines or primary cells ablates protein function, enabling assessment of loss-of-function phenotypes such as altered lipid composition, membrane defects, and growth arrest. Knockout models are essential for determining gene essentiality and for validating drug targets.
Point Mutation
CRISPR point mutation knock-in introduces specific amino acid substitutions (e.g., catalytic dead mutants) to dissect enzyme mechanism and separate catalytic from non-catalytic functions. This approach is valuable for studying disease-associated mutations in phospholipid enzymes.
Knock-in
Knock-in of epitope tags (e.g., GFP, HA) or fluorescent proteins at endogenous loci allows real-time tracking of phospholipid enzymes and transfer proteins without overexpression artifacts. Tagged knock-in models are used to study protein localization, dynamics, and interactions.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression elevates phospholipid enzyme levels to study gain-of-function effects, such as increased lipid synthesis or altered signaling. Overexpression models help identify rate-limiting steps and potential oncogenic roles.
How EDITGENE Supports phospholipid metabolic process Research
Researchers studying phospholipid metabolic process-related genes often need to determine whether a candidate gene is causally involved in lipid homeostasis, membrane dynamics, or disease pathogenesis. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for phospholipid metabolic process research.
Frequently Asked Questions About phospholipid metabolic process
What is phospholipid metabolic process?
Phospholipid metabolic process (GO:0006644) is the set of chemical reactions and pathways involving phospholipids, including their synthesis, remodeling, transport, and degradation.
What genes are involved in phospholipid metabolic process?
Key genes include PCYT1A, PEMT, MBOAT1/2, PLA2G4A, PLCB1, PITPNA, CERT1, ABCA1, TMEM41B, and CLCC1, among others.
Why is phospholipid metabolism important?
It maintains membrane integrity, supports signaling, and its dysregulation is linked to cancer, neurodegeneration, and metabolic disorders.
What diseases are associated with phospholipid metabolic process?
Cancer, Alzheimer's disease, Parkinson's disease, Tangier disease, non-alcoholic fatty liver disease, and chorea-acanthocytosis.
How can CRISPR be used to study phospholipid metabolism?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of phospholipid metabolic genes in cells and animal models.
What methods are used to study phospholipid metabolism?
Lipidomics, fluorescence imaging, CRISPR screening, enzyme assays, and proteomics are commonly used.
What is the role of TMEM41B in phospholipid metabolism?
TMEM41B acts as an ER scramblase required for lipoprotein biogenesis and lipid homeostasis.
What is the role of CLCC1 in phospholipid metabolism?
CLCC1 governs ER bilayer equilibration to maintain lipid homeostasis.
How is phospholipid metabolism regulated?
It is regulated by SREBPs, nuclear receptors, post-translational modifications, and feedback inhibition by lipid products.
What are phospholipid transfer proteins?
They are proteins that shuttle phospholipids between membranes, such as PITPNA, CERT1, and OSBP.
Conclusion
Phospholipid metabolic process (GO:0006644) is a fundamental biological process that governs membrane biogenesis, lipid signaling, and cellular homeostasis. Its dysregulation underlies numerous human diseases, making it a rich area for therapeutic targeting. Advances in CRISPR technology and lipidomics have accelerated the discovery of new genes and mechanisms, offering hope for novel interventions. Continued research into phospholipid metabolism will deepen our understanding of cell biology and disease pathogenesis.
References
- 1. Vance JE. 2015. Phospholipid synthesis and transport in mammalian cells.. Traffic 16(1):1-18 PMID: 25243850
- 2. Huang D et al.. 2021. TMEM41B acts as an ER scramblase required for lipoprotein biogenesis and lipid homeostasis.. Cell Metab 33(8):1655-1670.e8 PMID: 34015269
- 3. Wu L et al.. 2026. CLCC1 governs ER bilayer equilibration to maintain lipid homeostasis.. Nature 652(8109):471-480 PMID: 41741642
- 5. McMurray WC et al.. 1972. Phospholipid metabolism.. Annu Rev Biochem 41(10):129-60 PMID: 4570957
- 6. Tamura Y et al.. 2014. Phospholipid transport via mitochondria.. Traffic 15(9):933-45 PMID: 24954234
- 7. Yang Y et al.. 2018. Phospholipid subcellular localization and dynamics.. J Biol Chem 293(17):6230-6240 PMID: 29588369
- 8. Dowhan W. 1991. Phospholipid-transfer proteins.. Curr Opin Cell Biol 3(4):621-5 PMID: 1772656
